VanEck Pharmaceutical ETF
PPH
#1102
ETF rank
A$1.74 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
A$156.31
Share price
0.01%
Change (1 day)
11.87%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of February 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of February 2026: 0.36%